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Effects of acetate and bicarbonate hemodialysis on cardiac function in
chronic dialysis patients. Previous studies have suggested that acetate
hemodialysis causes myocardial depression. This study examines the
acute effects of hemodialysis using, alternately, bicarbonate and acetate
in the dialysate, on cardiac function in ten patients. These patients were
also studied during acetate dialysis using a large surface area (SA)
dialyzer. Each patient was dialyzed for 4 hr with: (1) 1.0 m2 SA dialyzer
and bicarbonate dialysate; (2) 1.0 m2 SA dialyzer and acetate bath, and;
(3) 2.5 m2 SA dialyzer and acetate dialysate. All studies were performed
during isovolemic dialysis to separate the effects of changes in cardiac
filling volume with hemodialysis, from changes in myocardial contrac-
tility. Myocardial function, as assessed by pre- and postdialysis echo-
cardiographically derived fractional shortening (Fs) and mean velocity
of circumferential shortening (VCF), improved (P < 0.05) to the same
extent, after all three dialysis treatments. This occurred despite greater
increases (P < 0.002) in pH and bicarbonate after bicarbonate dialysis
and decreases (P < 0.05) in P02, Pco2 and bicarbonate after acetate
dialysis with 2.5 m2 SA dialyzer. These results indicate that diffusive
dialysis with both acetate and bicarbonate dialysate improves myocar-
dial function and do not support the view that acetate influx during
dialysis can lead to myocardial depression.
Effets de l'hémodialyse avec acetate ou bicarbonate sur Ia fonction
cardiaque chez des malades hemodialysés chroniques. Des etudes antér-
ieures ont suggeré que l'hemodialyse a l'acétate entraine une dépres-
sion myocardique. Cette étude examine les effets aigus de l'hémodia-
lyse en utilisant a tour de role, du bicarbonate et de l'acétate dans le
dialysat sur Ia fonction cardiaque de dix malades. Ces malades ont
également eté étudiés pendant une dialyse avec acetate en utilisant un
dialyseur a large surface (SA). Chaque malade a été dialysé pendant 4
heures avec (1) un dialyseur SA 1.0 m2 et un dialysat avec bicarbonate;
(2) un dialyseur SA 1.0 m2 et un bain acetate; et (3) un dialyseur SA 2,5
m2 et un dialysat avec acetate. Toutes les etudes ont été faites pendant
une dialyse iso-volumique afin de séparer les effets des modifications du
volume de remplissage cardiaque par l'hemodialyse des modifications
de Ia contractilité myocardique. La fonction myocardique, mesurée par
le raccourcissement fractionnel (Fs) mesuré par echocardiographie pré
et post-dialytique et par Ia rapidité moyenne du raccourcissement
circonférentiel (VCF), s'est améliorée (P < 0,05) de Ia méme facon
après les trois types de dialyse. Cela s'est produit malgré des augmenta-
tions plus grandes (P < 0,002) du pH et du bicarbonate après dialyse au
bicarbonate, et des diminutions (P < 0,05) de P0,, Pco2 et bicarbonate
après dialyse avec acetate avec un dialyseur SA de 2,5 m2. Ces résultats
indiquent que La dialyse par diffusion avec un dialysat avec acetate
comme avec bicarbonate améliore Ia fonction myocardique, et n'ap-
porte par de preuves que l'influx d'acétate pendant Ia dialyse peut
conduire a une depression myocardique.
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For conventional hemodialysis sodium acetate has been used
to formulate the dialysate in place of sodium bicarbonate. The
use of acetate was initiated to prepare dialysate in concentrated
form without precipitation of calcium and magnesium salts [I].
Although acetate has been shown to be metabolized readily in
the dialysis patient [1—31, several studies have described hemo-
dynamic instability in many patients dialyzing against an ace-
tate-containing bath [4—7]. The hemodynamic instability has
been attributed to peripheral vasodilatation and myocardial
depression occurring from acetate metabolism [4—10] and has
generally improved with sodium bicarbonate dialysis, though
recent studies [11, 12] have challenged these observations. The
study by Wehle et al [12] has stressed, instead, the importance
of osmolality changes during dialysis, rather than the source of
the buffer used in the dialysate, as the etiology of dialysis-
related hypotension.
While the vasodilatory effects of acetate have been reported
widely [4—9], it is not clear whether acetate influx during
hemodialysis leads to any direct depression of myocardial
function, particularly in stable maintenance hemodialysis pa-
tients. In the present study, we have compared the effects of
equivalent bicarbonate and acetate dialyses on left ventricular
function in a chronic dialysis patient population that had no
clinical evidence of cardiac dysfunction. Previous studies [2, 3]
have shown that dialysis surface area can influence the influx of
acetate and the incidence of acetate intolerance during dialysis.
Therefore, myocardial function was studied during acetate
dialysis with both small (1.0 m2) and large (2.5 m2) surface area
dialyzers in this group of patients.
The purpose of the present investigation was to identify any
deleterious effects of acetate influx on myocardial function
during hemodialysis, particularly with large surface area dialyz-
ers, and to evaluate the possible advantages of the use of
bicarbonate dialysate on cardiac performance in stable chronic
dialysis patients.
Left ventricular function was assessed from echocardiog-
raphy performed before and after each dialysis session. Previ-
ous echocardiographic studies have shown that cardiac function
may improve after dialysis [13—15] using an acetate bath.
However, since ultrafiltration dialysis usually results in de-
creases in body weight and blood pressure, the improvement in
ejection phase indices of cardiac function might have resulted
from favorable changes in ventricular loading [16] rather than
from enhanced left ventricular contractility. To study whether
acetate in the dialysate unfavorably influences any inotropic
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effect of hemodialysis, all studies were performed during diffu-
sive dialysis without ultrafiltration to keep ventricular loading
constant.
Methods
Study population. Ten patients, seven male and three female,
with chronic stable renal failure on maintenance hemodialysis
were selected for study. Their mean age was 53 years (range, 27
to 72 years) and mean time on dialysis was 20.8 months (range,
2 to 54 months). None of the patients had clinical history of
angina or congestive heart failure, and no patient was taking
digitalis, /3-blockers, or antihypertensive medications at the
time of the study. Patients receiving these drugs were studied
after such medications had been discontinued for at least 2
weeks. One patient had diabetes mellitus and was on daily
insulin therapy. The study was approved by the University of
Texas Medical Branch Institutional Review Board, Galveston,
Texas, and all patients gave written informed consent.
Hemodialysis treatment. Three separate studies were per-
formed in each patient: (1) dialysis for 4 hr using 1.0 m2 surface
area (SA) parallel-plate dialyzer (Gambro 17 , Gambro Lun-
dia, Barrington, Illinois) with a standard bicarbonate bath; (2)
dialysis for 4 hr with standard acetate bath using 1.0 m2
(Gambro 17 t) parallel-plate dialyzer; and (3) dialysis for 4 hr
using acetate bath but with a 2.5 m2 SA hollow fiber (Cordis-
Dow, Miami, Florida) dialyzer. Previous studies [2, 3] have
shown significant acetate influx during dialysis with this dialyz-
er. The acetate bath contained sodium 139 mEq/liter, chloride
106.5 mEq/liter, acetate 35 mEq/liter, calcium 3.5 mEq/liter,
potassium 2.0 mEq/liter, and magnesium 1.0 mEq/liter. The
bicarbonate bath was prepared by mixing sodium bicarbonate
(containing sodium bicarbonate 39 mEq/liter and sodium chlo-
ride 20 mEq/liter) with acid concentrate containing sodium 80
mEq/liter, chloride 86 mEq/liter, calcium 3.5 mEq/liter, potassi-
um 2.0 mEq/liter, magnesium 1.0 mEq/Iiter, and acetic acid 4.0
mEq/liter. After mixing, the concentrated dialysate was propor-
tioned 35:1 by a delivery system (Drake Willock, Portland,
Oregon) to give final dialysate concentration of sodium 139
mEq/liter, chloride 106.5 mEq/liter, bicarbonate 35 mEq/liter,
calcium 3.5 mEq/liter, potassium 2.0 mEq/liter, magnesium 1,0
mEq/liter, and acetate 4 mEq/liter.
Special care was taken to keep the blood flow rate and
dialysate flow rate constant at 200 and 500 mI/mm, respectively,
and to prevent any ultrafiltration during dialysis. This was
accomplished by keeping the dialysate negative pressure at 0
mm Hg throughout dialysis and weighing the patients at 15-mm
intervals and replacing any weight loss with normal saline. No
major symptoms were encountered during dialysis with any of
the three procedures. After postdialysis echocardiography,
isolated ultrafiltration was performed for 1 to 1.5 hr to remove
the weight gained between the dialysis sessions. The patients
were not restudied after ultrafiltration. For all patients the
interdialytic interval between each study was kept constant
(approximately 40 hr), Blood was drawn prior to and at the end
of each dialysis for hematocrit, electrolytes, BUN, creatinine,
calcium and phosphorus, and arterial blood gases.
Echocardiography. Echocardiography was performed pre-
and within 1 hr postdialysis by the same observer, using a two-
dimensional ultrasonograph (E for M/Honeywell, Electronics
for Medicine, Honeywell Inc., Littleton, Colorado). The pa-
tients were studied in the recumbent position with the transduc-
er placed in the third, fourth, and fifth intercostal space,
depending on the size of the patient. An optimal short-axis
circular or almost circular image at the widest point of the left
ventricle below the tips of the mitral valve leaflet was central-
ized within the display arc and the M-mode cursor directed
across the left ventricular cavity at the widest point. M-mode
tracings were recorded on a Honeywell strip chart recorder at a
paper speed of 25 to 50 mm/sec. The two-dimensional image
and cursor were used to ensure that the M-mode echographic
images were obtained from the same point in the left ventricular
cavity despite alterations in cardiac position produced by
dialysis [17].
All echocardiographic measurements were made according to
the guidelines of the American Society of Echocardiography
[18]. Left ventricular function was assessed by (1) fractional
shortening, Fs (%), which was calculated as Dd-Ds/Dd x 100,
where Dd and Ds were the left ventricular transverse diameters
at end-diastole (Dd) and end-systole (Ds), respectively, and (2)
velocity of circumferential fiber shortening, VCF (circ/sec) =
Fs/LVET where LVET = left ventricular ejection time. Left
ventricular ejection time was obtained from a simultaneously
recorded aortic valve echogram. The LVET was normalized to
heart rate (LVET1) using Weissler's equation [19]. All ultra-
sound measurements and calculations were made using the
average of at least three cardiac cycles and by two observers.
Coefficients of correlation greater than 0.90 were obtained by
the observers for the echographic measurements. Blood pres-
sure was measured by standard sphygmomanometry by two
observers.
Statistical analysis. Statistical analysis was performed with a
Student's t test for paired data and with an analysis of variance
procedure. A P value of less than 0.05 was considered
significant.
Results
The clinical and biochemical data for each of the three
dialysis protocols are displayed in Table 1. There were no
alterations in mean body weight, systolic and mean arterial
pressure, and hematocrit. Serum creatinine and potassium were
reduced significantly and total serum calcium rose postdialysis.
The change in serum creatinine was greater (P < 0.05) after
acetate dialysis using a 2.5 m2 SA dialyzer than after acetate
and bicarbonate dialysis with 1.0 m2 SA dialyzers. However,
similar pre/post changes in serum potassium and total calcium
occurred during all three studies (Fig. I). The changes in arterial
blood gases with dialysis are depicted in Table 1 and Figure 2.
After both acetate and bicarbonate dialysis utilizing the small
SA dialyzers (1.0 m2), there was a significant rise in arterial pH
and bicarbonate but no change in arterial P02 and Pco2. The
increase in pH and bicarbonate was greater (P < 0.002) during
bicarbonate dialysis. Dialysis with "high efficiency" dialyzers
(2.5 m2 SA) resulted in no change, postdialysis, in arterial pH or
P02 but significant falls in arterial Pco2 and bicarbonate. The
slight rise in P02 after bicarbonate dialysis using 1.0 m2 SA
dialyser was significantly different (P < 0.05) from the slight fall
in P02 after acetate dialysis with 1.0 m2 and 2.5 m2 SA
dialyzers.
The echocardiographic data are shown in Table 2. There was
no change in left ventricular end-diastolic diameter (Dd) with all
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Table 1. Clinical and biochemical data in ten patients before and after acute dialysis
three treatment protocols, indicating constant cardiac preload,
a finding which confirms that isovolemic dialysis was achieved.
Fractional shortening (Fs) and mean velocity of circumferential
fiber shortening (VCF) improved significantly after all three
dialysis studies. The mean increase in Fs varied from 6.5 to
8.1%; the mean VCF increase was 17 to 20%. There was no
difference in the improvement in left ventricular function after
dialysis with the three different treatment protocols (Fig. 1).
Heart rate did not change when patients were dialyzed using
1.0 m2 SA dialyzers, but there was a slight but significant
increase in heart rate (P < 0.01) after dialysis with 2.5 m2 SA
dialyzers. However, the change in heart rate with the larger
dialyzers was not significantly different from the change during
dialysis (with either acetate or bicarbonate baths) using the
smaller dialyzers. Left ventricular ejection time normalized to
heart rate (LVET1) did not change after any of the dialysis
treatments.
Discussion
Left ventricular dysfunction is common in endstage renal
disease. Pathogenetic factors include anemia, pressure-volume
overload, electrolyte and metabolic disturbances, accelerated
atherosclerosis, and retention of uremic toxins [20]. Ultrafiltra-
tion dialysis [13—15, 21] rapidly alters hemodynamics with
decreases in body weight, plasma volume, mean arterial pres-
sure, and Dd. The effect on left ventricular function, as as-
sessed by echocardiographic studies, is variable; there may be
no change or it might improve [13—15].
Previous studies have described a vasodilatory effect of
acetate on the peripheral circulation. While there is consider-
able evidence that acetate can produce a decrease in vascular
resistance [4—9, 22, 23], there are discrepancies regarding its
effects on myocardial contractility. Kirkendol et al [8] reported
reduced myocardial contractility with very rapid bolus doses of
sodium acetate in dogs and concluded from these studies that
acetate was a myocardial depressant. Liang and Lowenstein
[22], however, have demonstrated that slow infusions of ace-
tate, with step-wise increments in the infused dose, lead to
increases in cardiac output, myocardial contractility, and coro-
nary blood flow in dogs. These observations, in anesthetized
dogs, were confirmed by Kirkendol et al [231 in a later study,
where they infused sodium acetate at a steady rate, rather than
in bolus doses.
Aizawa et al [7] have evaluated the effects of acetate and
bicarbonate dialysis on myocardial function, as assessed by
systolic time interval measurements, in chronic hemodialysis
patients. These investigators noted an increase in the ratio of
pre-ejection period to ejection time (PEP/LVET), indicating
depression of myocardial function, during both acetate and
bicarbonate dialysis. However, the ratio was significantly high-
er after acetate dialysis, suggesting a more profound depression
of cardiac function after hemodialysis using acetate. Milutino-
vich, Bekhett, and Lapp [101 have also reported depressed left
ventricular function during acetate dialysis based on the mea-
surement of systolic time intervals. Chen, Friedman, and Del
Monte [24] have shown that systolic time intervals are unreli-
able indices of left ventricular function during ultrafiltration
dialysis, where there is simultaneous alteration in cardiac
Dialysis
1.0 m2 Surface area
dialyzer bicarbonate
dialysate
1.0 m2 Surface area
dialyzer acetate dialysate
2.5 m2 Surface area
dialyzer acetate dialysate
Prc Post Pre Post Pre Post
Body weight, kg 69.3 69.3'
±6.0
69.2 69.2b
±6.1
69.7 69.7b
±6.1
Systolic BP, mm Hg 135.0 l34.0' 135.0 132.Ob 137.0 l35.Ob
Mean BP, mm Hg 93.0 92.Ob 92.0 86.Ob 91.0 90.Oh
Hematocrit, % 26.0 26.0
±2.2
26.0 25.0"
±1.9
25.0 25.Ob
Serumcreatinine,mg/d/ 14.8 7.6e 14.1 7.7' 14.7 6.5'
Total serum calcium, mgld! 9.1 10.0' 9.06 9.89'
±0.16
9.14 10.36'
Serum potassium, mEqiliter 4.7 3.3'
±0.13
4.6 3.2' 5.0 3.3'
Arterial pH 7.36 7.48'
±0.02
7.38 7.42d
±0.01
7.40 744b
Arterial P02, mm Hg 94.0 100.0" 102.0 94.0" 103.0 94.0"
Arterial Pco2, mm Hg 33.8 35.3" 32.5 33.0" 34.3 27.7"
Arterial bicarbonate, mEqiliter 18.3 25.0' 18.5 20.7' 20.5 17.3"
SEM.
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Fig. 1. Changes in total serum calcium, potassium and mean velocity of
circumferentialfiber shortening (VCF) with different dialysis protocols.
Plotted values are mean SEM. Hatched rectangles represent bicar-
bonate dialysis with 1.0 m2 SA dialyzer, shaded rectangles represent
acetate dialysis with 1.0 m2 SA dialyzer, and open rectangles, acetate
dialysis with 2.5 m2 SA dialyzer.
preload and afterload. They reported improved left ventricular
function during regular dialysis with acetate-containing dialy-
sate despite a fall in arterial P02 [24].
In the present study, a positive inotropic effect was noted
after diffusive dialysis without ultrafiltration. This improvement
occurred during equivalent dialyses using either acetate or
bicarbonate as the buffer source in the dialysate, despite a
significantly greater increase in arterial pH and bicarbonate
during bicarbonate dialysis. Moreover, in the same group of
patients, use of a larger surface area dialyzer (which has been
previously reported [2, 31 to result in significant increases in
plasma acetate concentration during dialysis) and acetate dialy-
sate, did not result in attenuation of the inotropic effect of
hemodialysis. The ejection phase indices of function improved
during "high efficiency" dialysis, despite a significant fall in
arterial bicarbonate, Pco2, and P02 when compared to bicar-
bonate dialysis.
Our studies do not support direct depression of myocardial
function as a result of acetate gain by the patient even during
high efficiency dialysis. Serum acetate levels were not mea-
sured in this study, however, and it is possible that our patients
had adequate capacity for acetate metabolism. This is suggested
by the presence of normal pre-dialysis pH and the observation
that pH did not decrease significantly during dialysis despite a
fall in bicarbonate [25]. Moreover, all our patients were stable
on chronic dialysis, without any serious cardiovascular compli-
cations, and mean pre-dialysis left ventricular function was
normal. We cannot exclude the possibility that in patients with
Fig. 2. Changes in P02, Pco2 and HC03 with different dialysis
treatments. Mean sEM; shaded areas are the same as in Figure 1. The
numbers in parentheses represent the following: (1) P < 0.05, acetate
dialysis with either 1.0 m2 or 2.5 m2 SA dialyzer versus bicarbonate
dialysis with 1.0 m2 SA dialyzer; (2) P < 0.002, acetate dialysis with 2.5
m2 SA dialyzer versus acetate and bicarbonate dialysis with 1.0 m2 SA
dialyzer; (3) P < 0.001, acetate dialysis with 2.5 m2 SA dialyzer versus
acetate and bicarbonate dialysis with 1.0 m2 SA dialyzer.
depressed cardiac function, and/or with limited ability to metab-
olize acetate, myocardial depression could occur during acetate
dialysis.
The validity of echocardiography in serial evaluation of left
ventricular dimensions and contractile state has been demon-
strated previously [171, In the present study, left ventricular
volume was not calculated from the echocardiographic dimen-
sions, to avoid the assumptions inherent in such calculations
[261. Moreover, mean VCF—the measurement of which does
not require calculation of left ventricular volumes—is the most
widely accepted echocardiographic measurement of myocardial
contractile state [26] and appears to be a more sensitive index
than ejection fraction to follow alterations in cardiac perform-
ance with hemodialysis [27].
With the exception of one study [281, previous studies have
not considered the effect of changing cardiac filling volume in
assessing the contractile state of the left ventricle. Therefore,
postdialysis changes in cardiac performance, including the
usual improvement in ejection phase indices, might result from
favorable alterations in ventricular loading rather than any
changes in myocardial contractility [16]. Although not mea-
sured directly, the constancy of body weight, systolic, and
mean blood pressure and Dd in our studies, suggest that during
these dialysis treatments, left ventricular preload and afterload
did not change, and that dialysis resulted in an acute positive
inotropic effect as previously reported [27, 28]. The improve-
Ca K VCF
P02 PC02 HC03-
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
—0.2
—0.4
—0.6
—0.8
—1.0
—1.2
—1.4
—1.6
—1.8
15
10
5
—5
—10
—15
(3)
(2)
(1)
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Table 2. Echocardiographic data in ten patients before and after acute dialysis'
Dialysis
1.0 m2 Surface area dialyzer
bicarbonate dialysate
1.0 m2 Surface area dialyzer
acetate dialysate
2.5 m2 Surface area dialyzer
acetate dialysate
Pre PostPre Post Pre Post
Heart rate, beats/mm
Dd, cm
Ds, cm
LVETI, msec
Fs, %
VCF, circlsec
77.0 81.Oh
±2.8
5.1 5.1i
±0.2
3.2 2.8"
±0.2
422.0 419.0"
±4.0
36.9 45Ød
±3.0
0.88 1.07"
±0.07
80.0 85.Ob
±2.2
5.0 5.lh
±0.2
3.2 2.9b
±0.2
418.0 415.0"
35.8 42.3c
0.86 1.02"
82.0 93.Od
53 53b
±0.1
3.3 3Qb
±0.1
414.0 408.0"
±13.0
36.4 43.4'
0.88 1.06c
Abbreviations: Dd, left ventricular end-diastolic diameter; Ds, left ventricular end-systolic diameter; LVET1, normalized left ventricular ejection
time; Fs, fractional shortening of left ventricle; VCF, mean velocity of circumferential fiber shortening.
a Values expressed as mean SEM.
P = NS.
P < 0.05.
P < 0.01.
ment in myocardial contractility with acute dialysis was much
less striking in our study. However, predialysis mean Fs and
VCF in our group of patients was within the normal range,
whereas the five patients studied by Nixon et al [28] had
depressed myocardial function before dialysis. Predialysis car-
diac function [14] has been shown to influence the myocardial
response to ultrafiltration dialysis, and it might also determine
any changes in cardiac inotropy accompanying isovolemic
dialysis.
The possible mechanisms involved in the inotropic effect of
diffusive dialysis are not resolved by our observations. The
simultaneous changes in calcium and potassium and removal of
uremic toxins might be responsible for the improved cardiac
function, in addition to changes in pH and bicarbonate. The role
of pH and bicarbonate changes (in the inotropic effect of acute
dialysis), in chronic dialysis patients with normal pre-dialysis
pH, is probably small, since left ventricular function improved
to the same extent during all three dialysis studies, despite
greater increases in pH and bicarbonate during bicarbonate
dialysis. A recent report by Henrich and Nixon [29] suggests
that the increase in serum calcium during dialysis is responsible
for the improved myocardial contractility after acute diffusive
dialysis. In addition, a fall in serum potassium might be
important, since Haddy et al [301 have demonstrated that any
improvement in cardiac inotropy due to increase in serum
calcium concentration is enhanced by simultaneous decrease in
serum potassium level. In the present study, the increase in
serum calcium and decrease in serum potassium occurred to the
same extent during all three dialysis treatments (Fig. 1), and this
was accompanied by similar changes in Fs and mean VCF with
dialysis.
In conclusion, the present study demonstrates a positive
inotropic effect of diffusive dialysis in chronic hemodialysis
patients; this improvement is not unfavorably influenced by use
of acetate as the sole buffer in the dialysate, even during high
efficiency dialysis, in the otherwise stable chronic hemodialysis
patient.
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